Trending stocks today
CRISPR Therapeutics AG (CRSP-Q)
NASDAQ:CRSP
55.66
0.75
(1.33%) 1d
Financials
Technical Analysis
Related posts
Top Biotech and Pharma Stocks to Bet on Cancer Cure & ControlBiotechnology, Gene-editing and Medical Research Stocks to Buy in 2019Top Stocks with Groundbreaking Potential in the DNS Manipulation and Gene-Editing MarketsThis summary was created by AI, based on 1 opinions in the last 12 months.
The reviews from different experts indicate that CRISPR Therapeutics AG has recently made significant improvements in research and development, leading to major gains in the business. However, due to the unpredictable nature of health discoveries, it is difficult to accurately predict the future of the business. Overall, the recommendation is to hold onto this stock considering these recent advancements.
$61.620
Unknown
- «
- ‹
- 1
- ›
- »
CRISPR Therapeutics AG(CRSP-Q) Rating
Ranking : 3 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 1
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 1
CRISPR Therapeutics AG(CRSP-Q) Frequently Asked Questions
What is CRISPR Therapeutics AG stock symbol?
CRISPR Therapeutics AG is a American stock, trading under the symbol CRSP-Q on the NASDAQ (CRSP). It is usually referred to as NASDAQ:CRSP or CRSP-Q
Is CRISPR Therapeutics AG a buy or a sell?
In the last year, 1 stock analyst published opinions about CRSP-Q. 0 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for CRISPR Therapeutics AG.
Is CRISPR Therapeutics AG a good investment or a top pick?
CRISPR Therapeutics AG was recommended as a Top Pick by on . Read the latest stock experts ratings for CRISPR Therapeutics AG.
Why is CRISPR Therapeutics AG stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is CRISPR Therapeutics AG worth watching?
1 stock analyst on Stockchase covered CRISPR Therapeutics AG In the last year. It is a trending stock that is worth watching.
What is CRISPR Therapeutics AG stock price?
On 2024-04-24, CRISPR Therapeutics AG (CRSP-Q) stock closed at a price of $55.66.
Recent improvements in R&D have been major gain in the business. Is hard to predict future of business given nature of health discoveries. Would recommend holding it.